Vishal Dey - Concepedia

Author

Vishal Dey

University Hospital Crosshouse ORCID

Also Known As

Dey, Vishal, V Dey, VISHAL DEY, Vishal Dey

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

University Hospital Crosshouse University of Oxford University of Edinburgh University of Nottingham Nottingham University Hospitals NHS Trust

About

Vishal Dey is an author at University Hospital Crosshouse specializing in medicine, covid-19, and clinical trials.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	937
2	Hospital Medicine	1	1	555
3	Antibiotics	1	1	555
4	Clinical Microbiology	1	1	555
5	Clinical Trials	1	1	382

Vishal Dey

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2023	126
Telehealth: Acceptability, clinical interventions and quality of life in peritoneal dialysis Vishal Dey, Audrey Jones, Elaine Spalding SAGE Open Medicine	2016	42
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Amr E. Abbas, Fatima Abbas, The Lancet Diabetes & Endocrinology	2023	34
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial Saul N. Faust, Richard Haynes, Christine E. Jones, The Lancet Child & Adolescent Health	2024	31
A National Registry Study of Patient and Renal Survival in Adult Nephrotic Syndrome A. Kolb, Peter J. Gallacher, Jacqueline Campbell, Kidney International Reports	2020	30
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort Kaitlin J. Mayne, Jennifer S. Lees, Elaine Rutherford, Clinical Kidney Journal	2022	24

Page 1